JBS S.A. announced it is investing $22 million in the first phase of the JBS Biotech Innovation Center—a research, development and innovation center for cultivated protein in Brazil.
In total, the JBS Biotech Innovation Center will require approximately $62 million in investments in three phases and will be the largest biotech center in Brazil. The initial objective will be to make cultured protein production process more efficient, scalable and economically competitive. The center will employ 25 postgraduates, doctors, specialists and administrative support staff when completed.
“The JBS Biotech Innovation Center reinforces our commitment to the cultivated protein sector, consolidates our position as one of the main players in this very promising market, and reinforces our commitment to offering innovative and high-quality products to our consumers,” said Jerson Nascimento Jr., global director of supply and innovation at JBS.
